Yaz, Yasmin and Ocella birth control pills contain drospirenone, a synthetic progestogen and have been linked to dangerous side effects including heart attack, stroke, pulmonary embolism, deep vein thrombosis and blood clots.  

Yaz and Yasmin  are manufactured by Bayer Healthcare.   Bayer’s Yasmin was first approved for use in the United States in 2001; Yaz was approved in 2006.  Ocella, the generic version of Yasmin, was approved in 2008 and is marketed and distributed by Teva Pharmaceuticals.

In 2009 two European studies alerted the public that there was an increased risk of these dangerous side effects when compared to older generation birth control pills.  However, Bayer, the manufacturer of Yaz and Yasmin, disputed those findings.

In September 2011, the FDA issued a Safety Communication reporting that it “remained concerned” about the potential increased risk of blood clots associated with Yaz and Yasmin.

In October and November 2011, three more studies were released, one of which was an independent FDA study, and confirmed the two initial European Studies’ findings from 2009.

Despite this overwhelming evidence, Bayer continues to dispute these findings.

If you or a loved one has suffered a heart attack, stroke, pulmonary embolism, deep vein thrombosis or blood clot while taking Yaz, Yasmin or Ocella birth control you may be entitled to compensation.

Ennis & Ennis P.A. has been investigating Yaz and Yasmin claims since 2009.  Contact the Yaz lawyers of Ennis & Ennis, P.A. today by calling toll free (800)856-6405 or by completing the online form at www.The-Yaz-Lawyers.com for a free, confidential consultation.

Do not discontinue the use of any medication, including Yaz, Yasmin or Ocella birth control, without first consulting with your physician.